
Industrials · Environmental & Facilities Services
$84.20
-2.05%
Vol: 80K
Monday, June 15, 2026
No material news in the last 48 hours.
No material news in the last 48 hours.
On May 14, Veralto board approved a $0.13 quarterly cash dividend payable July 31. The dividend follows strong Q1 results with sales up 6.7% YoY to $1.42B and adjusted EPS up 13% to $1.07. The company raised full-year adjusted EPS guidance to $4.20-$4.28 supported by acquisitions of In-Situ and GlobalVision (~$1B) and a cost-optimization program targeting $65-$75M in annual savings by 2028. UBS raised its price target to $101 from $99. The risk: water-quality strength is being partially offset by a 1% decline in product quality and innovation, and the acquisition integration introduces execution risk.
Veralto reported Q1 2026 sales up 6.7% y/y with adjusted EPS of $1.07, beating estimates, and raised full-year adjusted EPS guidance to $4.20–$4.28. The company invested about $1B acquiring In-Situ and GlobalVision and completed a $300M buyback of 3,224,855 shares. At the May 13 annual meeting, shareholders elected four Class III directors, ratified Ernst & Young as auditor, and approved executive pay. UBS raised its price target to $101 from $99 on May 1. The combination of an earnings beat, guidance hike, portfolio expansion via M&A and capital return supports a positive sentiment.
No material news in the last 48 hours.
On May 14, 2026, Veralto's board approved a $0.13 quarterly cash dividend payable July 31 to shareholders of record June 30. Despite the announcement, shares hit a 52-week low of $84.97 amid broader market pressure. UBS raised its price target to $101 (from $99) and Deutsche Bank to $103 (from $102) following Q1 2026 results showing 6.7% revenue growth to $1.42B and adjusted EPS of $1.07, beating $0.88 forecasts. The company raised full-year adjusted EPS guidance to $4.20-$4.28 and launched a cost-optimization program targeting $65-$75M in annual savings by 2028. CAO Bernard Skeete sold shares on May 1 at $88.21.
On May 14, 2026, Veralto Corporation declared a quarterly cash dividend of $0.13 per share payable July 31 to shareholders of record June 30, with the stock closing near $85.27 on the day. The company's Q1 2026 sales rose 6.7% YoY to $1.42B with adjusted EPS of $1.07, prompting management to raise full-year adjusted EPS guidance to $4.20-$4.28. Veralto also initiated a cost-optimization program targeted to yield $65-$75M in annual run-rate savings by 2028. CAO Bernard Skeete sold 300 shares on May 1 at $88.21. Risk: water-treatment capex cyclicality and FX could weigh on the analytical instruments segment near term, though the recurring service and consumables mix provides downside support.
Veralto reported strong Q1 2026 results with sales of $1.42B, adjusted EPS of $1.07, and net income of $254M; management raised full-year adjusted EPS guidance to $4.20-$4.28 with ~7% sales growth and 13% adjusted EPS growth. The company invested ~$1B acquiring In-Situ and GlobalVision in Q1 and completed a $300M buyback for 3.22M shares. Chief Accounting Officer Bernard Skeete sold 300 shares on May 1 at $88.21. UBS raised PT to $101 (May 1) and Deutsche Bank to $103 (Apr 30). Stock traded $85.97-$87.63 on May 11. Risk: water/quality industrial demand cyclicality.
On May 12, 2026, Representative Gilbert Ray Cisneros disclosed purchasing $1,001-$15,000 in Veralto shares on May 1. Veralto's CAO sold 300 shares on May 1 at $88.21. Q1 2026 results beat with $1.07 adjusted EPS vs $1.02 consensus and revenue of $1.42B (up 6.8% YoY). The company invested ~$1B acquiring In-Situ and GlobalVision and completed a $300M buyback of 3.22M shares. Veralto raised FY 2026 EPS guidance to $4.20-$4.28. Average analyst price target is $109.73, implying 24.51% upside from $88.13.
Veralto reported strong Q1 2026 results with sales of $1.42B (+7%) and adjusted EPS of $1.07 (+13% YoY), raising full-year adjusted EPS guidance to $4.20-$4.28. The company deployed ~$1B in Q1 on acquisitions (In-Situ and GlobalVision) and completed a $300M buyback of 3.22M shares. UBS raised its price target to $101 from $99 on May 1. CAO Bernard Skeete sold 300 shares at $88.21 on May 1. As of May 11, the stock traded between $85.97-$87.63, with average analyst PT of $109.73 implying 24.5% upside. Risk: recent share price weakness suggests mixed investor sentiment near term.
VLTO Q1 2026 sales rose 6.7% YoY to $1.42B with adjusted EPS up roughly 13% to $1.07. The company raised full-year adjusted EPS guidance to $4.20-$4.28 supported by a new cost-optimization program expected to deliver $65-$75M in savings by 2028. In Q1 Veralto invested about $1B acquiring In-Situ and GlobalVision and completed a $300M buyback of 3.22M shares. UBS raised PT to $101 from $99 (Hold). Deutsche Bank raised to $103 from $102, while Baird cut to $103, Citi to $102, Barclays to $113. CAO Bernard Skeete sold 300 shares at $88.21 on May 1. Shares trading near $86-88, lower end of 52-week range.
Veralto reported Q1 2026 sales of $1.42B (up 6.7% YoY) with non-GAAP EPS of $1.07 (beat $1.01 consensus), raising full-year adjusted EPS guidance to $4.20-$4.28. Company announced acquisition of GlobalVision and completion of $300M share repurchase. Analysts bullish: UBS raised PT to $101 from $99 (May 1); Deutsche Bank raised PT to $103 from $102 (April 30). 26 analysts have average PT of $109.73 (implying 24.51% upside). 52-week range: $84.99-$110.11.
Veralto Corporation reported strong Q1 2026 results on May 5-6, 2026, with $1.42B in sales (+6.7% YoY) and non-GAAP EPS of $1.07 vs. $1.01 consensus, representing a 6% beat. The company raised full-year adjusted EPS guidance to $4.20-$4.28 (from prior range) and announced approximately 7% sales growth and 13% adjusted EPS growth expectations. Veralto invested $1B in acquiring In-Situ and GlobalVision in Q1 and completed a $300M share buyback (3.2M shares).
Veralto Corporation reported Q1 2026 sales of $1.42 billion (up 6.7% YoY) and raised full-year adjusted EPS guidance to $4.20-$4.28. Quarterly earnings of $1.07 per share exceeded estimate of $1.00 (6.5% beat). Company invested approximately $1 billion in Q1 acquisitions of In-Situ and GlobalVision while completing $300 million share buyback program (3.22M shares). Water Quality and Product Quality & Innovation segments driving growth. UBS raised price target to $101 from $99 with Hold rating on May 1. Market cap of $21.65 billion with P/E of 22.61. However, stock showed negative returns over recent week/month/YTD. Mixed analyst sentiment with targets ranging $99-$138. Company's strategic M&A and organic growth position it well but valuation concerns persist.
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| WMWASTE | $217.69 | -0.03% | -2.2% | 23.6x | 0.49 | $87.4B |
| RSGREPUBLIC | $208.55 | +0.22% | -3.0% | 25.8x | 0.44 | $64.0B |
| ROLROLLINS | $47.17 | -11.04% | -2.9% | 37.9x | 0.79 | $25.5B |
| VLTOVERALTO | $84.20 | -2.05% | -0.9% | 18.5x | 0.93 | $21.1B |
| CATCATERPILLAR | $933.44 | +7.79% | +0.2% | 29.1x | 1.63 | $398.8B |
| GEGENERAL | $346.55 | +14.84% | +5.5% | 34.8x | 1.35 | $315.3B |
Price below 200d MA — bearish structure.